Paying user area
Try for free
Allergan PLC pages available for free this week:
- Statement of Comprehensive Income
- Common-Size Income Statement
- Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
- Analysis of Reportable Segments
- Enterprise Value to EBITDA (EV/EBITDA)
- Selected Financial Data since 2005
- Current Ratio since 2005
- Price to Operating Profit (P/OP) since 2005
- Price to Book Value (P/BV) since 2005
- Aggregate Accruals
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Allergan PLC for $22.49.
This is a one-time payment. There is no automatic renewal.
We accept:
Total Debt (Carrying Amount)
Based on: 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31).
Debt item | Description | The company |
---|---|---|
Total long-term debt and capital leases, including current portion (carrying amount) | Sum of the carrying values as of the balance sheet date of all debt plus capital lease obligations. | Allergan PLC total debt decreased from 2017 to 2018 and from 2018 to 2019. |
Total Debt (Fair Value)
Dec 31, 2019 | |
---|---|
Selected Financial Data (US$ in thousands) | |
Senior Notes | |
Margin Loan | |
Term Loan Indebtedness | |
Other borrowings | |
Capital leases | |
Total long-term debt and capital leases, including current portion (fair value) | |
Financial Ratio | |
Debt, fair value to carrying amount ratio |
Based on: 10-K (reporting date: 2019-12-31).
Weighted-average Interest Rate on Debt
Weighted-average interest rate on debt:
Interest rate | Debt amount1 | Interest rate × Debt amount | Weighted-average interest rate2 |
---|---|---|---|
Total | |||
Based on: 10-K (reporting date: 2019-12-31).
1 US$ in thousands
2 Weighted-average interest rate = 100 × ÷ =